Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …

Background Medication-related osteonecrosis of the jaw (MRONJ), which was first reported
as bisphosphonate-related osteonecrosis of the jaw (BRONJ) in bisphosphonate users, is a …

Objectives his review evaluated implant survival in geriatric patients (≥ 75 years) and/or the
impact of systemic medical conditions. Materials and Methods Systematic literature searches …

Medication‐related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of
antiresorptive and antiangiogenic agents; it is a potentially painful and debilitating condition …

Background Antiresorptive agents such as bisphosphonates and denosumab, as well as
angiogenesis inhibitors, may induce medication-related osteonecrosis of the jaw (MRONJ) …

Objectives A considerable portion of the adult population has received and/or is receiving
treatment with antiresorptive drugs (ARD s). It is thus relevant to assess possible side effects …

In modern medicine, implants have become a prevalent solution for replacing or supporting
damaged body parts across various specialties, from orthopedics to dentistry. However …

Objective This paper aims to describe the 2023 update position paper on MRONJ
developed by the Italian Societies of Oral Pathology and Medicine (SIPMO) and of …

Purpose To conduct a systematic review of the literature to detect the effect of anti-resorptive
drugs (ARDs) and their administration characteristics in the development of medication …

Background To analyze articles that studied patients submitted to diphosphonates therapy
and who received dental implants before, during or after bisphosphonate (BP) treatment …